Human Longevity (Oncology Division) Overview

  • Status
  • Acquired/​Merged

  • Latest Deal Type
  • M&A

  • Financing Rounds
  • 1

Human Longevity (Oncology Division) General Information

Description

Provider of next-generation sequencing services based in San Diego, California.

Contact Information

Ownership Status
Acquired/Merged
Financing Status
Corporate Backed or Acquired
Corporate Office
  • 4570 Executive Drive
  • San Diego, CA 92121
  • United States
Primary Industry
Drug Discovery
Other Industries
Biotechnology
Acquirer
NeoGenomics Laboratories
Vertical(s)
Life Sciences
Corporate Office
  • 4570 Executive Drive
  • San Diego, CA 92121
  • United States

Want detailed data on 3M+ companies?

What you see here scratches the surface

Request a free trial

Want to dig into this profile?

We’ll help you find what you need

Learn more

Human Longevity (Oncology Division) Valuation & Funding

Deal Type Date Amount Valuation/
EBITDA		 Post-Val Status Debt

This information is available in the PitchBook Platform. To explore Human Longevity (Oncology Division)‘s full profile, request access.

Request a free trial

Human Longevity (Oncology Division) Former Investors

Investor Name Investor Type Holding Investor Since Participating Rounds Contact Info

This information is available in the PitchBook Platform. To explore Human Longevity (Oncology Division)‘s full profile, request access.

Request a free trial

Human Longevity (Oncology Division) FAQs

  • Where is Human Longevity (Oncology Division) headquartered?

    Human Longevity (Oncology Division) is headquartered in San Diego, CA.

  • What industry is Human Longevity (Oncology Division) in?

    Human Longevity (Oncology Division)’s primary industry is Drug Discovery.

  • Is Human Longevity (Oncology Division) a private or public company?

    Human Longevity (Oncology Division) is a Private company.

  • What is the current valuation of Human Longevity (Oncology Division)?

    The current valuation of Human Longevity (Oncology Division) is .

  • What is Human Longevity (Oncology Division)’s current revenue?

    The current revenue for Human Longevity (Oncology Division) is .

  • Who are Human Longevity (Oncology Division)’s investors?

    Human Longevity has invested in Human Longevity (Oncology Division).

  • When was Human Longevity (Oncology Division) acquired?

    Human Longevity (Oncology Division) was acquired on 10-Jan-2020.

  • Who acquired Human Longevity (Oncology Division)?

    Human Longevity (Oncology Division) was acquired by NeoGenomics Laboratories.

Data Transparency

  • Meet our data hygiene team

    Discover how our experts ensure you’re getting the most accurate financial data in the industry.

    Read blog »

  • How PitchBook sources data

    Our data operations team has logged over 3.5 million hours researching, organizing, and integrating the information you need most.

    Discover our process »